| Influence of canrenoate-K and cardiac glycosides on their tissue distribution and elimination. | |
| | |
MedLine Citation:
|
PMID: 578485 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The combination of cardiac glycosides and canrenoate-potassium (CR-K) produces synergistic effects on hemodynamics. On the other hand, CR-K antagonizes digitalis-induced cardiac arrhythmias. Therefore, it was the purpose of this study to determine interactions between these substances, particularly of their myocardial uptake. The additional administration of CR-K leads to significantly higher concentrations of digoxin and ouabain in heart, liver, adrenal gland and spleen. Contrary to this, additional digoxin reduces the concentration of CR-K in the tissue. Particularly obvious is the reduced concentration in the kidney, adrenal gland, pancreas, brain and spleen. The renal excretion of digoxin and ouabain is reduced by the additional administration of CR-K, while digoxin accelerates the CR-K excretion within the first 60 min after application. Metabolic interference was not detected in the combination of cardiac glycosides and CR-K. The mechanisms for the interactions between cardiac glycosides and CR-K during the distribution phase are discussed. The inhomogenous interference of their myocardial uptake makes a common cardiac receptor for the synergistic effect of cardiac glycosides and CR-K rather unlikely. CR-K does not have a suppressant effect on digitalis-induced arrhythmias due to any diminution of the glycoside uptake by myocardial tissue. |
| | |
Authors:
|
J Kuhlmann; V Kötter; H F Vöhringer; N Rietbrock; R Schröder |
Related Documents
:
|
21825865 - False heart-to-mediastinum ratio of i-123 metaiodobenzylguanidine due to right ventricu... 20467475 - Sarcomere control mechanisms and the dynamics of the cardiac cycle. 22508795 - Long-term (>10 years) clinical outcomes of first-in-man biodegradable poly-l-lactic aci... 9166145 - Commotio cordis: clinical implications of blunt cardiac trauma. 6661925 - Thrombolytic therapy of acute myocardial infarction. 15769445 - Healing after myocardial infarction. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Arzneimittel-Forschung Volume: 27 ISSN: 0004-4172 ISO Abbreviation: Arzneimittelforschung Publication Date: 1977 Jul |
Date Detail:
|
Created Date: 1977-10-31 Completed Date: 1977-10-31 Revised Date: 2003-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0372660 Medline TA: Arzneimittelforschung Country: GERMANY, WEST |
Other Details:
|
Languages: eng Pagination: 1505-9 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Canrenoate Potassium / metabolism, pharmacology* Chromatography, Thin Layer Digoxin / metabolism, pharmacology* Dogs Drug Interactions Myocardium / metabolism Ouabain / metabolism, pharmacology* Pregnadienes / pharmacology* Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Pregnadienes; 20830-75-5/Digoxin; 2181-04-6/Canrenoate Potassium; 630-60-4/Ouabain |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Local treatment of thoracic empyema with tri-tetracycline complexes.
Next Document: Acute nonlymphocytic leukemia in patients with nodular lymphoma.